StockVS

NYSE · Specialty Chemicals · USD

Cabot Corporation (CBT) Stock Analysis

Cabot Corporation (CBT) is a Specialty Chemicals stock listed on NYSE and quoted in US Dollar.

CBT

$81.48

+$0.29 (+0.36%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare CBT with… →

CBT Key Statistics

As of Sep 4, 2026
Trading
Open
$80.26
Previous Close
$81.19
Day's Range
80.24–82.40
52-Week Range
58.33–94.53
Volume
284.10K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.83
Valuation
Market Cap
$4.21B
P/E Ratio
22.82
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
11.66
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
1.00
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
1.16
EPS (ttm)Profit attributable to each share over the last twelve months.
3.57
Financials (FY)
Revenue (FY)
$3.71B−7.04%
Net Income (FY)
$331.00M−12.89%
Profit marginThe share of revenue left as profit after all costs and taxes.
5.23%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
51.63M
1-Year Return
+2.44%
Dividend and dates
Dividend
$1.85+2.27%
Ex-Dividend Date
August 28, 2026
Earnings Date
November 2, 2026estimated
Avg Volume
510.85K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

CBT Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+24.34%
2025−25.67%
2024+11.25%
2023+27.63%
2022+21.38%
2021+28.40%
2020−2.16%
2019+14.25%
2018−28.70%
2017+24.65%
2016 (partial year)+4.39%

As of September 4, 2026.

CBT Revenue and Earnings by Fiscal Year

FY ends September
Fiscal yearRevenueNet incomeNet margin
2025$3.71B$331.00M8.9%
2024$3.99B$380.00M9.5%
2023$3.93B$445.00M11.3%
2022$4.32B$209.00M4.8%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$3.71B$940.00M$621.00M$331.00M8.9%
2024$3.99B$960.00M$614.00M$380.00M9.5%
2023$3.93B$839.00M$529.00M$445.00M11.3%
2022$4.32B$885.00M$572.00M$209.00M4.8%

Annual figures as reported, in the company's reporting currency. As of September 30, 2025.

CBT Dividend History

$1.78+5.3% vs 2024

Dividends per share, 2025 · 4 payments

YearDividends per sharePaymentsChange
2026*$0.922
2025$1.784+5.3%
2024$1.694+7.6%
2023$1.574+6.1%
YearDividends per sharePaymentsChange
2026 (partial year)$0.922
2025$1.784+5.3%
2024$1.694+7.6%
2023$1.574+6.1%
2022$1.484+4.2%
2021$1.424+1.4%
2020$1.404+1.4%
2019$1.384+5.7%
2018$1.314+4.8%
2017$1.254+315.0%
2016$0.301

Most recent payment: $0.46 per share, ex-dividend May 29, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

CBT Valuation vs Specialty Chemicals Median

Median of 71 stocks
MetricCBTSpecialty Chemicals medianvs median
P/E22.8228.7121% below
P/S ratio1.161.6831% below
Profit margin5.23%0.08%5.1 pts above

Medians across 71 Specialty Chemicals stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Cabot Corporation (CBT) at $4.21B. The company sits in the Basic Materials sector, in the Specialty Chemicals industry. The company reports 4,064 employees.

Over the past 52 weeks the price has ranged from $58.33 to $94.53. The most recent close on file for CBT is $81.48, dated September 4, 2026. That is +$0.29 (+0.36%) against the previous close. The latest close sits 39.69% above that 52-week low.

Financial Health

In fiscal 2025, Cabot Corporation reported revenue of $3.71B. That is −7.04% against the prior fiscal year, when revenue was $3.99B. The same year closed with net income of $331.00M. That is −12.89% against the prior fiscal year. Profit margin runs at 5.23%. That is 5.1 percentage points above the Specialty Chemicals median of 0.08%. Trailing earnings per share are 3.57.

Across the 4 fiscal years on file, revenue moves from $4.32B in 2022 to $3.71B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

On trailing earnings, the shares are priced at 22.82 times earnings. That is 20.52% below the Specialty Chemicals median of 28.71. The forward P/E on file is 11.66. The PEG ratio, which sets the P/E against expected earnings growth, reads 1. The price-to-sales ratio is 1.16. On price-to-sales that is 31.03% below the Specialty Chemicals median of 1.68. The medians here are taken across 71 Specialty Chemicals companies that report the metric.

The reported beta is 0.83. Daily returns over the trailing 10 years annualize to a volatility of 35.44%. The trailing one-year price return is +2.44%. Across 10 years the annualized return works out at +7.35%.

Growth & Income

Shareholders receive a dividend, yielding 2.27% on the latest price. That is 0.4 percentage points above the Specialty Chemicals median yield of 1.83%. At the indicated rate that is $1.85 a share a year. The ex-dividend date on file is August 28, 2026. Dividends are recorded for 11 calendar years; 2026 shows 2 payments totalling $0.92 a share. The year before, 2025, totalled $1.78 a share.

2026 is still running; the price is +24.34% year to date. Across the complete calendar years on file, 2021 returned +28.40% and 2018 returned −28.70%. Of the 9 complete calendar years on file, 6 finished higher.

Peer Comparison

Cabot Corporation (CBT) operates in the Specialty Chemicals industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Cabot Corporation CBT $4.21B 22.8
Linde plc LIN $220.15B 30.9
The Sherwin-Williams Company SHW $81.01B 30.8
Ecolab Inc. ECL $78.29B 37.4

The Specialty Chemicals industry average P/E ratio is 28.7x. Cabot Corporation trades at a P/E of 22.8.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Specialty Chemicals Stocks

View all Specialty Chemicals stocks →

Popular Basic Materials Stocks

View all Basic Materials stocks →

About Cabot Corporation

Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through two segments, Reinforcement Materials and Performance Chemicals. The company offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions. It also provides specialty carbons for use in inks, coatings, plastics, adhesives, toners, batteries, and displays; conductive additives and fumed alumina used in lead acid and lithium-ion batteries for electric vehicles; fumed silica used in adhesives, sealants, cosmetics, batteries, inks, toners, silicone elastomers, coatings, polishing slurries, and pharmaceuticals; and fumed alumina for use in various products, including inkjet media, lighting, coatings, cosmetics, and polishing slurries. In addition, it offers aerogel, a hydrophobic, silica-based particle to use in various thermal insulation and specialty chemical applications; masterbatch and conductive compound products that are used in automotive, industrial, packaging, infrastructure, agriculture, consumer products, and electronics industries; and inkjet colorants for inkjet printing applications, as well as carbon nanotubes and fumed metal oxides. The company sells its products through distributors and sales representatives in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Cabot Corporation was founded in 1882 and is headquartered in Boston, Massachusetts.

Visit website →